Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SCTX compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
SCTX
Scribe Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
SCTX
Scribe Therapeutics, Inc.
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Event sensitivity
Desk
News
Calendar
Saved
Search
Event sensitivity
release-day history · min 6 releases
Method
›
Insufficient release history: SCTX.
SCTX
Scribe Therapeutics, Inc.
Change
15.78
▲
+1.96%
· post 15.93
Mkt cap
$38.9M
Revenue
$2M
Q2 FY26
Revenue
—
AMGN
Amgen Inc
Change
460.55
▲
+0.06%
· post 460.42
Closed
Nov 6 '26
Mkt cap
$249.0B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
vs
Compare
Closed
Nov 6 '26
SCTX
Scribe Therapeutics, Inc.
vs
AMGN
Amgen Inc
15.78
▲
+1.96%
post 15.93
Price
460.55
▲
+0.06%
post 460.42
$38.9M
Mkt cap
$249.0B
Q2 FY26
$2M
Revenue
$10.4B
Q3 FY26
—
Revenue
$36.8B
FY25
Change
Change
SCTX
15.78
▲
+1.96%
vs
AMGN
460.55
▲
+0.06%
Closed
Nov 6 '26